Polaris Genomics
Polaris Genomics is a veteran-owned biotech startup leveraging AI-powered genomics to develop objective diagnostics and novel therapeutics for mental health and neuropsychiatric conditions. Their core product, the ADAPT Neuropsychiatric Biomarker Discovery Platform™, integrates a targeted gene panel with over 1000 transcriptomic biomarkers, a deep analytics engine, and a growing data repository to enable biomarker-based diagnostics and therapeutics from blood samples. This platform supports researchers and pharmaceutical companies in advancing precision mental health care by improving diagnosis accuracy, reducing clinical trial costs, and enabling individualized treatments. Polaris Genomics collaborates with pharma, academic, clinical, CRO, government, and research partners, positioning itself as a pioneer in biologically-based mental health solutions with a strong leadership team experienced in military, medicine, and federal research.
Polaris Genomics
Polaris Genomics is a veteran-owned biotech startup leveraging AI-powered genomics to develop objective diagnostics and novel therapeutics for mental health and neuropsychiatric conditions. Their core product, the ADAPT Neuropsychiatric Biomarker Discovery Platform™, integrates a targeted gene panel with over 1000 transcriptomic biomarkers, a deep analytics engine, and a growing data repository to enable biomarker-based diagnostics and therapeutics from blood samples. This platform supports researchers and pharmaceutical companies in advancing precision mental health care by improving diagnosis accuracy, reducing clinical trial costs, and enabling individualized treatments. Polaris Genomics collaborates with pharma, academic, clinical, CRO, government, and research partners, positioning itself as a pioneer in biologically-based mental health solutions with a strong leadership team experienced in military, medicine, and federal research.